Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Leukemia
|
April 1, 1994
Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2
R Longnecker
Advances in Cancer Research
|
May 20, 2000
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
R Longnecker
Methods in Molecular Biology (Clifton, N.J.)
|
May 19, 2001
In vitro assays for the detection of protein tyrosine phosphorylation and protein tyrosine kinase activities
S Fruehling, R Longnecker
Archives of Virology
|
August 14, 1999
Epstein-Barr virus (EBV) infection visualized by EGFP expression demonstrates dependence on known mediators of EBV entry
P Speck, R Longnecker
Journal of Virology
|
May 1, 1990
A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1
R Longnecker, E Kieff
Science (New York, N.Y.)
|
May 1, 1987
Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome
R Longnecker, B Roizman
Journal of the National Cancer Institute
|
November 18, 2000
Infection of breast epithelial cells with Epstein-Barr virus via cell-to-cell contact
P Speck, R Longnecker
Virology
|
March 7, 2002
LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways
M Merchant, R Longnecker
Virology
|
September 1, 1997
The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
S Fruehling, R Longnecker
Journal of Virology
|
May 1, 1986
Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the alpha 47 gene
R Longnecker, B Roizman
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Leukemia
|
April 1, 1994
Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2
R Longnecker
Advances in Cancer Research
|
May 20, 2000
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
R Longnecker
Methods in Molecular Biology (Clifton, N.J.)
|
May 19, 2001
In vitro assays for the detection of protein tyrosine phosphorylation and protein tyrosine kinase activities
S Fruehling, R Longnecker
Archives of Virology
|
August 14, 1999
Epstein-Barr virus (EBV) infection visualized by EGFP expression demonstrates dependence on known mediators of EBV entry
P Speck, R Longnecker
Journal of Virology
|
May 1, 1990
A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1
R Longnecker, E Kieff
Science (New York, N.Y.)
|
May 1, 1987
Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome
R Longnecker, B Roizman
Journal of the National Cancer Institute
|
November 18, 2000
Infection of breast epithelial cells with Epstein-Barr virus via cell-to-cell contact
P Speck, R Longnecker
Virology
|
March 7, 2002
LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways
M Merchant, R Longnecker
Virology
|
September 1, 1997
The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
S Fruehling, R Longnecker
Journal of Virology
|
May 1, 1986
Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the alpha 47 gene
R Longnecker, B Roizman
Page
of 7